SCHEMBL28547490

SCHEMBL28547490

CC(C)(C)OC(=O)NC(=S)NC1CCCCC1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.77
EPHX1 P07099 4/20 0.57
ALDH1A1 P00352 1/20 0.52
TP53 P04637 1/20 0.52
CYP3A4 P08684 1/20 0.52
BTK Q06187 1/20 0.49
CA1 P00915 1/20 0.48
CA2 P00918 1/20 0.48
SMN1; SMN2 Q16637 3/20 0.47
NPC1 O15118 5/20 0.47
RAB9A P51151 4/20 0.47
HDAC4 P56524 1/20 0.46
HDAC1 Q13547 1/20 0.46
HDAC6 Q9UBN7 1/20 0.46
LMNA P02545 1/20 0.46
MAPK1 P28482 1/20 0.44
DUSP3 P51452 1/20 0.44
PTPN5 P54829 1/20 0.44
PTPN11 Q06124 1/20 0.44
MEN1 O00255 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20332059 0.87 GAA (0.60) GAAEPHX1ALDH1A1TP53CYP3A4
SCHEMBL20312537 0.85 GAA (0.58) GAAEPHX1ALDH1A1TP53CYP3A4
SCHEMBL28804033 0.84 GAA (0.68) GAAEPHX1ALDH1A1CYP3A4BTK
SCHEMBL60196 0.84 GAA (0.68) GAAEPHX1ALDH1A1CYP3A4BTK
SCHEMBL28536966 0.84 GAA (0.56) GAAEPHX1ALDH1A1BTKCA1
SCHEMBL31487056 0.83 GAA (0.55) GAAEPHX1BTKCA1CA2
Ethane SCHEMBL27689700 0.82 GAA (0.66) GAAEPHX1ALDH1A1CYP3A4BTK
SCHEMBL1829584 0.82 BTK (0.67) GAAEPHX1BTKCA1CA2
SCHEMBL23012500 0.81 GAA (0.54) GAAEPHX1ALDH1A1BTKCA1
Bicarbonate SCHEMBL1457456 0.81 BTK (0.66) GAAEPHX1ALDH1A1BTKCA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11479546-B2 Antimalarial hexahydropyrimidine analogues UCB Biopharma SRL 2022-10-25 US disclosed
EP-3774741-B1 ANTIMALARIAL HEXAHYDROPYRIMIDINE ANALOGUES UCB Biopharma SRL (BE) 2022-06-08 EP disclosed
CN-111936472-A Anti-malarial hexahydropyrimidine analogues UCB生物制药有限责任公司 2020-11-13 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11479546-B2 Antimalarial hexahydropyrimidine analogues G6PD, DPYD, DHODH GAA 3464/4885EPHX1 1283/4885ALDH1A1 329/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.